Cargando…
Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs
Evodiamine has been documented to possess activities in numerous cancer cells. Our preliminary study showed that A549 cells were insensitive to evodiamine. In this paper, A549 cells are sensitive to nanoemulsive evodiamine (EVONE) through an efficient intracellular and systematic delivery. EVONE ent...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630310/ https://www.ncbi.nlm.nih.gov/pubmed/29029410 http://dx.doi.org/10.18632/oncotarget.17536 |
_version_ | 1783269196280365056 |
---|---|
author | Liu, Shan Chen, Dilong Yuan, Yuming Zhang, Xue Li, Yao Yan, Shenglei Zhang, Jingqing |
author_facet | Liu, Shan Chen, Dilong Yuan, Yuming Zhang, Xue Li, Yao Yan, Shenglei Zhang, Jingqing |
author_sort | Liu, Shan |
collection | PubMed |
description | Evodiamine has been documented to possess activities in numerous cancer cells. Our preliminary study showed that A549 cells were insensitive to evodiamine. In this paper, A549 cells are sensitive to nanoemulsive evodiamine (EVONE) through an efficient intracellular and systematic delivery. EVONE entered tumor cells by energy-dependent and mainly through clathrin-mediated endocytosis. EVONE exerted a higher cytotoxicity in a dose- and time-dependent manner. The enhanced induction of cell cycle arrest was ascribed to the down-regulation of cyclin B and cyclin dependent kinase 1, while the enhanced induction of apoptosis was due to the activation of caspase −3, −8 and −9 and the decreased B-cell lymphoma 2/ assaciated X protein ratio. Furthermore, the in vivo kinetic, bioavailability and in situ absorption characteristics of EVONE were much better than those of free evodiamine. The cancer cells insensitive to free chemodrugs became sensitive to nanoemulsive chemodrugs. |
format | Online Article Text |
id | pubmed-5630310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56303102017-10-12 Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs Liu, Shan Chen, Dilong Yuan, Yuming Zhang, Xue Li, Yao Yan, Shenglei Zhang, Jingqing Oncotarget Research Paper Evodiamine has been documented to possess activities in numerous cancer cells. Our preliminary study showed that A549 cells were insensitive to evodiamine. In this paper, A549 cells are sensitive to nanoemulsive evodiamine (EVONE) through an efficient intracellular and systematic delivery. EVONE entered tumor cells by energy-dependent and mainly through clathrin-mediated endocytosis. EVONE exerted a higher cytotoxicity in a dose- and time-dependent manner. The enhanced induction of cell cycle arrest was ascribed to the down-regulation of cyclin B and cyclin dependent kinase 1, while the enhanced induction of apoptosis was due to the activation of caspase −3, −8 and −9 and the decreased B-cell lymphoma 2/ assaciated X protein ratio. Furthermore, the in vivo kinetic, bioavailability and in situ absorption characteristics of EVONE were much better than those of free evodiamine. The cancer cells insensitive to free chemodrugs became sensitive to nanoemulsive chemodrugs. Impact Journals LLC 2017-04-28 /pmc/articles/PMC5630310/ /pubmed/29029410 http://dx.doi.org/10.18632/oncotarget.17536 Text en Copyright: © 2017 Liu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Liu, Shan Chen, Dilong Yuan, Yuming Zhang, Xue Li, Yao Yan, Shenglei Zhang, Jingqing Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title_full | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title_fullStr | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title_full_unstemmed | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title_short | Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
title_sort | efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630310/ https://www.ncbi.nlm.nih.gov/pubmed/29029410 http://dx.doi.org/10.18632/oncotarget.17536 |
work_keys_str_mv | AT liushan efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT chendilong efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT yuanyuming efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT zhangxue efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT liyao efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT yanshenglei efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs AT zhangjingqing efficientintracellulardeliverymakescancercellssensitivetonanoemulsivechemodrugs |